Competencies and contingencies in the expanding ART marketplace: is there a place for precision medicine.
作者信息
Albertini David F
机构信息
Bedford Research Foundation, Bedford, MA, USA.
出版信息
J Assist Reprod Genet. 2022 Apr;39(4):779-780. doi: 10.1007/s10815-022-02498-w.
Abstract
摘要
相似文献
1
Competencies and contingencies in the expanding ART marketplace: is there a place for precision medicine.
J Assist Reprod Genet. 2022 Apr;39(4):779-780. doi: 10.1007/s10815-022-02498-w.
2
Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
Am Soc Clin Oncol Educ Book. 2018 May 23;38:546-553. doi: 10.1200/EDBK_200759.
3
Personalized/Precision Medicine/Personalised Healthcare: the art of giving different names to the same thing?
Per Med. 2017 Nov;14(6):463-466. doi: 10.2217/pme-2017-0073. Epub 2017 Oct 26.
4
The dawn of precision medicine in HIV: state of the art of pharmacotherapy.
Expert Opin Pharmacother. 2018 Oct;19(14):1581-1595. doi: 10.1080/14656566.2018.1515916. Epub 2018 Sep 20.
5
Targeting DNA repair in precision medicine.
Adv Protein Chem Struct Biol. 2019;115:135-155. doi: 10.1016/bs.apcsb.2018.10.005. Epub 2018 Dec 5.
6
Expanding our understanding of fetal genetic diseases: the beginning of in utero precision medicine.
BJOG. 2021 Jan;128(2):430. doi: 10.1111/1471-0528.16541. Epub 2020 Nov 23.
7
Excavating the Personal Genome: The Good Biocitizen in the Age of Precision Health.
Hastings Cent Rep. 2020 May;50 Suppl 1(Suppl 1):S54-S61. doi: 10.1002/hast.1156.
8
Global Precision Oncology: A Call to Action on Expanding Access to Targeted Cancer Therapies.
Oncologist. 2021 May;26(5):353-355. doi: 10.1002/onco.13708. Epub 2021 Mar 5.
9
Personalized medicine enters the US marketplace: KRAS, anti-EGFR monoclonal antibodies, and colon cancer.
Am J Ther. 2009 Nov-Dec;16(6):477-9. doi: 10.1097/MJT.0b013e3181baf276.
10
Can precision medicine advance psychiatry?
Ir J Psychol Med. 2021 Sep;38(3):163-168. doi: 10.1017/ipm.2020.79. Epub 2020 Jul 17.
本文引用的文献
1
Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity.
Sci Rep. 2022 Mar 25;12(1):5205. doi: 10.1038/s41598-022-08937-z.
2
Cell maturation: Hallmarks, triggers, and manipulation.
Cell. 2022 Jan 20;185(2):235-249. doi: 10.1016/j.cell.2021.12.012. Epub 2022 Jan 6.
3
Pannexins and Connexins: Their Relevance for Oocyte Developmental Competence.
Int J Mol Sci. 2021 May 31;22(11):5918. doi: 10.3390/ijms22115918.
4
The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Int J Mol Sci. 2019 Sep 26;20(19):4781. doi: 10.3390/ijms20194781.
5
Personalized and Cancer Models to Guide Precision Medicine.
Cancer Discov. 2017 May;7(5):462-477. doi: 10.1158/2159-8290.CD-16-1154. Epub 2017 Mar 22.
6
Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.
J Gynecol Oncol. 2016 Mar;27(2):e22. doi: 10.3802/jgo.2016.27.e22.
7
Comparison of preimplantation developmental competence after mouse oocyte growth and development in vitro and in vivo.
Theriogenology. 1998 Jan 15;49(2):415-22. doi: 10.1016/s0093-691x(97)00413-5.
8
Factors affecting the developmental competence of mouse oocytes grown in vitro: follicle-stimulating hormone and insulin.
Biol Reprod. 1998 Dec;59(6):1445-53. doi: 10.1095/biolreprod59.6.1445.
Zotero 插件